Latest Press Releases

2/2/10 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. Sciclone Pharmaceuticals, inc Sciclone Pharmaceuticals to Present at BIO CEO & Investor Conference

1/12/10 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone and Sigma-Tau Announce Positive Preliminary Results in Clinical Study Examining Zadaxin's Ability to Enhance Response to H1N1 Vaccine

1/11/10 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Provides 2009 Financial Update and Initial 2010 Sales Revenue Guidance

11/30/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Announces Commencement and Complete Enrollment of Clinical Study Examining Zadaxin's Ability to Enhance the H1N1 Vaccine led by European Partner, Sigma-Tau

11/23/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Announces Enrollment Completion in Phase 2 Oral Mucositis Trial of SCV-07

11/12/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Pharmaceuticals Announces Presentations of SCV-07 Data at Upcoming Medical Meetings

11/09/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Reports Financial Results and Provides Commercial and Pipeline Updates for the Third Quarter of 2009

11/03/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Pharmaceuticals to Present at Two November Investor Conferences

10/28/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Announces Corporate Restructuring and Workforce Reduction

10/21/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i SciClone Announces Enrollment of First Patient in its Phase 2 TRIAL of SCV-07 in Hepatitis C

10/02/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceuticals, i Phase 2 Trial of RP101 in Late-Stage Pancreatic Cancer Discontinued

09/04/09 Sciclone Pharmaceuitcals,inc. SciClone Pharmaceuticals, Inc. SciClone Pharmaceutica SciClone Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference

Worth Noting

April 17, 2009: SciClone Pharmaceuticals SciClone Pharmaceuticals SciClone Pharmacdeuticals SciClone eyes China to help bottom line; San Francisco Business Times

March 19, 2009: SciClone Pharmaceuticals SciClone Pharmaceuticals SciClone Pharaceuticals Sci SciClone Pharmaceuticals was named #19 in Silicon Valley Business Journal's Top Biotech/Biopharma Companies, ranked by most recently completed fiscal-year revenue

 More news